SI
SYNH

Sapience Investments’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Sapience Investments’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-177,680
Closed -$6.33M – 82
2023
Q1 		$6.33M Sell
177,680
-12,020
-6% -$436K 1.46% 37
2022
Q4 		$6.96M Sell
189,700
-31,894
-14% -$1.26M 1.46% 34
2022
Q3 		$10.4M Buy
221,594
+80,132
+57% +$5.18M 2.19% 10
2022
Q2 		$10.1M Sell
141,462
-15,363
-10% -$1.12M 1.9% 11
2022
Q1 		$12.7M Sell
156,825
-6,700
-4% -$567K 1.54% 24
2021
Q4 		$16.8M Sell
163,525
-2,640
-2% -$254K 1.91% 9
2021
Q3 		$14.5M Sell
166,165
-16,120
-9% -$1.46M 1.73% 13
2021
Q2 		$16.3M Sell
182,285
-31,932
-15% -$2.7M 2.03% 6
2021
Q1 		$16.2M Sell
214,217
-32,293
-13% -$2.43M 2.04% 10
2020
Q4 		$16.8M Buy
246,510
+15,980
+7% +$996K 2.34% 5
2020
Q3 		$12.3M Buy
230,530
+58,900
+34% +$3.51M 2.17% 6
2020
Q2 		$10M Sell
171,630
-71,495
-29% -$3.84M 1.84% 12
2020
Q1 		$9.58M Buy
243,125
+57,065
+31% +$3.34M 2.13% 7
2019
Q4 		$11.1M Sell
186,060
-10,340
-5% -$556K 1.55% 25
2019
Q3 		$10.4M Sell
196,400
-194,090
-50% -$9.96M 1.45% 25
2019
Q2 		$19.9M Buy
390,490
+72,875
+23% +$3.39M 2.72% 5
2019
Q1 		$16.4M Sell
317,615
-62,320
-16% -$3.02M 2.19% 9
2018
Q4 		$14.9M Buy
379,935
+16,955
+5% +$788K 2.44% 6
2018
Q3 		$18.7M Sell
362,980
-26,610
-7% -$1.3M 2.29% 9
2018
Q2 		$18.3M Sell
389,590
-223,710
-36% -$9.26M 2.42% 7
2018
Q1 		$21.8M Buy
613,300
+3,550
+0.6% +$139K 2.99% 3
2017
Q4 		$26.6M Buy
+609,750
New +$28.5M 3.6% 3

Other funds holding SYNH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Sapience Investments's SYNH Position: Q2 2023 in Review

Sapience Investments sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 177,680 shares — an estimated $6.33M sold.

Sapience Investments first reported a position in SYNH in Q4 2017 and held it in 22 quarters. The position peaked at $26.6M in Q4 2017. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

  • Sapience Investments reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Sapience Investments sold 177,680 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $6.33M.
  • Sapience Investments first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2017 and held it in 22 quarters.
  • Sapience Investments's Syneos Health, Inc. Class A Common Stock position peaked at $26.6M in Q4 2017.
  • 317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on Sapience Investments's 13F filing for Q2 2023, filed 14 Aug 2023.